Malaria Population Genomics · Notre Dame
Molecular epidemiology and parasite genomics in service of malaria control and elimination across Africa, Asia, and Latin America.
Explore our work41°42′13″N 86°13′51″W
Notre Dame, Indiana
McCourtney Hall East
Research in the Koepfli Lab uses molecular tools to interrogate the epidemiology of malaria and other infectious diseases. The lab continuously develops novel laboratory methods to diagnose, quantify, and genotype parasites and their transmission stages, then applies them to large, population-based surveys across endemic regions.
A central focus is the vast reservoir of asymptomatic, low-density infections that escape clinical detection entirely. Using ultrasensitive molecular diagnostics, the lab characterizes this hidden burden, maps transmission networks using GPS-informed parasite genotyping, and distinguishes imported from locally acquired infections to guide targeted interventions.
Collaborative fieldwork spans sub-Saharan Africa, South and Southeast Asia, and Latin America. The lab regularly welcomes researchers from endemic countries to Notre Dame for training, fostering genuine, long-term partnerships with institutions in the field.
Most malaria infections produce no fever and remain untreated. Using ultrasensitive molecular diagnostics, we characterize the full extent of the infection reservoir, including sub-microscopic parasitemia, to reveal the true epidemiological landscape that clinical surveillance misses entirely.
DiagnosticsTransmission is highly focal in space and time, yet the drivers of this heterogeneity are poorly understood. We combine parasite genotyping with GPS data to reconstruct transmission networks, distinguish imported from local infections, and identify persistent foci that resist standard control measures.
GenomicsNot all infections transmit equally to mosquitoes. By quantifying sexual-stage transmission forms, we investigate how infectivity varies across individuals, seasons, and settings. In western Kenya, we showed that parasites increase their investment in transmission during the wet season when vectors are most abundant.
TransmissionDeletions of P. falciparum genes hrp2 and hrp3 render standard rapid diagnostic tests blind to infection. We developed a high-throughput digital PCR method to screen isolates from numerous countries, mapping deletion frequencies and helping malaria control programs select appropriate diagnostics.
SurveillanceWe develop and validate amplicon deep-sequencing panels for microhaplotype genotyping of polyclonal infections, ddPCR quantification of transmission stages, and mobile nanopore sequencing in endemic field sites. Our tools lower the barrier for in-country genomic surveillance globally.
Methods DevelopmentOur work spans P. falciparum, P. vivax, P. malariae, and P. knowlesi. We use parasite genetic networks, relatedness analyses, and population genomic tools to understand how malaria is currently circulating in places such as the Ethiopian highlands, Kenya, Thailand, and other endemic settings. By mapping parasite connectivity, local transmission, and population structure, we generate evidence that can support surveillance and elimination strategies.
Population GeneticsField studies span Ethiopia (highlands, Gondar, Ziway), Kenya (western highlands, Kisumu), Zanzibar (pre-elimination setting), and multiple West African countries. Collaborative fieldwork addresses transmission heterogeneity, drug resistance surveillance, and spatial genomics in contexts ranging from high-endemic to near-elimination.
Research in Cambodia (Kampong Speu, Mondulkiri), Bangladesh (Chittagong Hill Tracts), Thailand, and Papua New Guinea investigates P. vivax relapse biology, population structure across continents, and the challenge of sustaining malaria control progress under low-endemic conditions with residual asymptomatic infections.
In collaboration with Fiocruz (Brazil) and partners across South America, the lab studies P. vivax diversity, drug resistance markers, and the interplay between human migration and parasite dispersal in low-transmission Amazonian settings where elimination efforts are increasingly feasible but complicated by forest malaria.
A key strand of our genomic work examines parasite populations within and across countries, using regional comparisons to study parasite flow, population structure, and drug resistance. When suitable datasets allow, these analyses are extended across continents to place regional patterns in a broader global context. Mobile laboratory deployments using Oxford Nanopore technology are also expanding genomic surveillance capacity in resource-limited endemic settings.
We work in close collaboration with research institutions, ministries of health, universities, and industry partners advancing malaria research and innovation. These partnerships connect field expertise, public health priorities, laboratory science, and technology development, forming the foundation of our collaborative approach to malaria genomics and molecular epidemiology.
Contact
We welcome PhD students, postdocs, visiting scholars, and collaborators working in molecular biology, bioinformatics, or infectious disease epidemiology. We are especially committed to long-term partnerships with scientists and institutions in malaria-endemic countries.
Write to us →